Economic Burden of Febrile Neutropenia in Solid Tumor and Lymphoma Patients: An Observational Study in Singapore.
نویسندگان
چکیده
in Solid Tumor and Lymphoma Patients – An Observational Study in Singapore Xiao-Jun Wang, B.Sc.(Pharm)1; Mabel Wong, MD2; Li-Yang Hsu, MD3; Alexandre Chan, PharmD, BCPS, BCOP 1,4 1 Department of Pharmacy, Faculty of Science, National University of Singapore, 2 Department of Medical Oncology, National Cancer Centre, Singapore 3 Department of Medicine, National University Health System Singapore, 4 Department of Pharmacy, National Cancer Centre, Singapore
منابع مشابه
Costs associated with febrile neutropenia in solid tumor and lymphoma patients – an observational study in Singapore
BACKGROUND The primary objective was to describe the total direct inpatient costs among solid tumor and lymphoma patients with chemotherapy-induced febrile neutropenia (FN) and the factors that were associated with higher direct cost. The secondary objective was to describe the out-of-pocket patient payments and the factors that were associated with higher out-of-pocket patient payments. METH...
متن کاملEpidemiology, management and economic impact of febrile neutropenia in oncology patients receiving routine care at a regional UK cancer centre.
BACKGROUND Febrile neutropenia (FN) is a potentially life-threatening complication following chemotherapy. The incidence and mortality of this condition varies according to cancer type and chemotherapy regimen. The aim of the study was to establish the incidence, risk, outcome, infectious cause and economic cost of FN in solid tumour patients within a routine oncology hospital setting. PATIEN...
متن کاملWhich One is More Effective Filgrastim or Lenograstim for Febrile Neutropenia with Solid Tumors
The chemotherapy-induced neutropenia causes mortality and morbidity at a significant rate (Aapro et al., 2011; Fontanella et al., 2014). Fever is frequently observed during chemotherapy-induced neutropenia. Neutropenia-related fever could be encountered for at least once in 10-50% of patients with solid tumor and >80% of patients with hematological malignancy (Freifeld et al., 2011). In patient...
متن کاملMain Determinants of Severe Neutropenia in Patients with Solid Tumors Receiving Adjuvant Chemotherapy
Background:Chemotherapy-induced neutropenia as a major toxicity of systemic chemotherapy is commonly associated with substantial mortality and morbidity, and thus identifying its determinants is necessary. This study was undertaken to identify main risk factors of severe neutropenia following adjuvant chemotherapy treatment in a community-based population of patients with cancer in Semnan, I...
متن کاملChemotherapy-induced Neutropenia in cancer patients with solid tumors in India
The present study was aimed to evaluate the incidences of chemotherapy-induced neutropenia and febrile neutropenia in the patients with solid tumors in India. The patients with carcinomas of breast, lung, ovary, colon, head and neck, and liver were divided in two groups. Group 1 was for the patients who experienced grade 0-2 neutropenia and Group 2 was for the patients with grade 3-4 neutropeni...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
دوره 17 7 شماره
صفحات -
تاریخ انتشار 2014